Gout Clinical Trials
255 clinical trials for Gout across international registries, including 25 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants — RECRUITING · PHASE2
- A Study of Dotinurad Versus Allopurinol in Participants With Gout — RECRUITING · PHASE3
- A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE) — RECRUITING · PHASE2
- Immediate Prescription of a Hypouricemic Treatment, Febuxostat, Compared to Its Delayed Administration — RECRUITING · PHASE3
- The Remote Monitoring of Gout Feasibility Study in Primary Care — RECRUITING · NA
- the Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or More — RECRUITING · PHASE4
- Drug-Drug Interaction Study of ABP-671 in Gout Patients — RECRUITING · PHASE1
- Tight Control of Gouty Arthritis Compared to Usual Care — RECRUITING · NA
- Dose Response of Exercise for Arthritis Management — RECRUITING · NA
- The Orienting Study — RECRUITING
- Tigulixostat (IBI128) vs Febuxostat in Gout — RECRUITING · PHASE3
- Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare — RECRUITING · PHASE2
- Time Required to Dissolve Urate Deposits — RECRUITING
- Purified Cortrophin® Gel Efficacy and Safety Study of 2 Dose Levels in Patients With Acute Gout Flares — RECRUITING · PHASE4
- Improving Gout Care After an ED Visit — RECRUITING · NA
- A Phase Ib Clinical Trial of Peguricase for Injection With Methotrexate in Patients With Uncontrolled Gout. — RECRUITING · PHASE1
- Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout — RECRUITING · PHASE4
- Metformin in Safety and Efficacy in Gouty Patients — RECRUITING · PHASE2
- Comparative Clinical and Biochemical Study Evaluating the Effectiveness of Metformin Versus Febuxostat on Gouty Obese Non-Diabetic Patients — RECRUITING · PHASE2
- Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and Hyperuricemia — RECRUITING · PHASE1
- Prevalence of Abnormalities in Ultrasonography of Joint and Tendons in Patients With Gout — RECRUITING
- Assessment of Physician Consideration of EPRO's, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Systemic Lupus, on the Frequency of Therapeutic Adjustments — RECRUITING
- CRYSTALILLE Cohort: Getting the Whole Picture of Crystal-related Arthropathies — RECRUITING
- ''Diagnostic value of optical spectral transmission in patients with inflammatory rheumatic diseases'' — RECRUITING
- A RANDOMIZED, DOUBLE-BLIND, ACTIVE AND PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ARHALOFENATE FOR PREVENTING FLARES AND REDUCING SERUM URIC ACID IN GOUT PATIENTS — RECRUITING
- Lesinurad and Allopurinol Combination Extension Study in Gout — COMPLETED · PHASE3
- A Phase 2, Multiple-Dose, Pharmacokinetic and Pharmacodynamic Study of RDEA594 in Gout Patients with Hyperuricemia and Gout with Renal Insufficiency — COMPLETED · PHASE2
- Anakinra versus treatment as usual in the treatment of acute gout — COMPLETED · PHASE3
- Study of Safety, PK, and Efficacy of Multiple Ascending Doses of HZBio1 in Patients With Gout — COMPLETED · PHASE1
- An Innovative Chinese Herbal Formula for the Treatment of Gout — COMPLETED · PHASE2
- Phase II Study to Evaluate Efficacy and Safety of D-0120 in Combination With Allopurinol in Subjects With Gout — COMPLETED · PHASE2
- A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout — COMPLETED · PHASE4
- To Evaluate the Influence of (LUA Probiotics) on Uric Acid — COMPLETED
- The Impact of Initiating Dotinurad Urate-Lowering Therapy at Different Time Windows on Gout Flare Resolution Time — NOT_YET_RECRUITING · PHASE4
- Musculoskeletal Ultrasound for Differentiating Rheumatoid and Gouty Arthritis — NOT_YET_RECRUITING
- Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients With Hyperuricemia — COMPLETED · PHASE1
- Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients — ACTIVE_NOT_RECRUITING · PHASE2
- Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302) — COMPLETED · PHASE3
- Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301) — ACTIVE_NOT_RECRUITING · PHASE3
- Using Gout Buddy to Enhance Gout Management — ACTIVE_NOT_RECRUITING · NA
- Gout in the ED and Improving Research Participation — ACTIVE_NOT_RECRUITING · NA
- A Therapeutic Confirmatory Study of Epaminurad Versus Febuxostat in Gout Patients — COMPLETED · PHASE3
- Tahiti-families: Polynesian Families of Gout Patients — COMPLETED · NA
- A Clinical Trial of HEC93077 in Chinese Healthy Subjects and HUA Patients With Single or Multiple Dosing — COMPLETED · PHASE1
- Study of the Correlation Between UltraSonography and Dual-Energy Computed Tomography Assessment of Urate Deposit — COMPLETED · NA
- Long-Term Risk of Gout in Living Kidney Donors — COMPLETED
- Epidemiology of Gout in French Polynesia — COMPLETED · NA
- Phone-Based Based Walk With Ease Program for Adults With Arthritis — COMPLETED · NA
- Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines - (DREAM) Probenecid vs Allopurinol — COMPLETED
- Pharmacist-Led Treat-to-Target Urate Lowering Therapy in Patients With Gout — NOT_YET_RECRUITING · NA
Refine this search